Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-046029)

Filing Details

Accession Number:: 0001209191-19-046029
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-08-15 08:39:07
Reporting Period:: 2019-08-13

Accepted Time:: 2019-08-15 08:39:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
876343	Lineage Cell Therapeutics Inc.	LCTX	Biological Products, (No Disgnostic Substances) (2836)	943127919

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1310683	M Brian Culley	C/O Lineage Cell Therapeutics, Inc. 2173 Salk Avenue, Suite 200 Carlsbad CA 92008	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2019-08-13	10,000	$1.01	84,531	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The number of common shares beneficially owned by the reporting person includes 15,411 additional common shares that were issued to the reporting person to maintain the intrinsic value of restricted stock unit awards immediately prior to the issuer's distribution of common stock of AgeX, Inc. See the issuer's proxy statement as filed with the Securities and Exchange Commission on June 14, 2019 for additional information.